Norbrook Laboratories Hexasol Injection (oxytetracycline & flunixin meglumine)
Recall announced August 9, 2018 by Norbrook Laboratories, Ltd, posted by the U.S. Food and Drug Administration (FDA). Reason: Crystallization: crystals observed suspended in the injectable solution. It affects farm animals. The agency has closed this recall.
- Where sold
- MO, TX, KS, Puerto Rico
- Last updated
- November 20, 2026
Products included
- Hexasol Injection (oxytetracycline & flunixin meglumine), 300mg oxytetracycline and 20mg flunixin per mL, 250 mL (NDC: 55529-016-04), 500 mL (NDC: 55529-016-05), Norbrook Laboratories Limited, Newry, BT35 6PU, Co. Down, Northern Ireland ([Expiry], Batch#: [April 2019] 7152-90A, 7152-91A, 7153 90A, 7173 98A, 7173 98B, 7175 90A; [February 2020] 8073-90A)
Read the official notice. Always compare the codes on your package with the official notice. It is the final word.
Has your pet used this product and seems unwell? Call your veterinarian or an emergency animal hospital now.
